ALATAWI, A. M. Metformin versus sodium glucose co-transporters inhibitors as first-line for atherosclerotic cardiovascular disease: A meta-analysis. Pakistan Journal of Medical Sciences, v. 40, n. 1, 16 Nov. 2023.